| Financial Year |
March 31 2023 |
| Monetary Funds |
469,646,805.68 |
| Held-for-trading Financial Assets |
220,969,000.00 |
| Notes Receivable |
379,000.00 |
| Accounts Receivable |
52,134,537.96 |
| Advances to Suppliers |
1,048,655.05 |
| Other Receivables |
13,860,406.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
121,275,989.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,985,075.65 |
| Total Current Assets |
888,827,791.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
7,365,816.21 |
| Fixed Assetes |
233,643,820.76 |
| Under-construction Projects |
17,296,051.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,149,826.71 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,370,069.64 |
| Deferred Income Tax Assets |
6,183,614.96 |
| Other Non-Current Assets |
548,672.60 |
| Sub-Total of Non-Current Assets |
317,557,872.15 |
| Total Assets |
1,206,385,663.60 |
| Short-Term Loans |
20,920,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
204,778,293.74 |
| Accounts Payable |
93,623,770.61 |
| Accounts Received In Advance |
387,176.62 |
| Employee Compensation Payable |
4,951,709.96 |
| Taxes Payable |
2,152,899.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
80,943,736.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,137,615.11 |
| Sub-Total of Current Liabilities |
417,646,087.48 |
| Long-term Loans |
1,001,469.18 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,189,085.02 |
| Total Liabilities |
418,835,172.50 |
| Paid-In Capital(Or Share Stock) |
129,171,152.00 |
| Capital Surplus |
482,865,707.11 |
| Surplus Reserve |
28,677,033.32 |
| LESS:Treasury Stock |
41,279,207.47 |
| Undistributed Profits |
188,115,806.14 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
787,550,491.10 |
| Owner's Equity（Stockholder's Equity） |
787,550,491.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,206,385,663.60 |
